An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques

A promising concept for human immunodeficiency virus (HIV) vaccines focuses immunity on the highly conserved transition state structures and epitopes that appear when the HIV glycoprotein gp120 binds to its receptor, CD4. We are developing chimeric antigens (full-length single chain, or FLSC) in whi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Vaccine Immunol
Päätekijät: Schwartz, Jennifer A., Prado, Ilia, Misamore, Johnathan, Weiss, Deborah, Francis, Jesse, Pal, Ranajit, Huaman, Maria, Cristillo, Anthony, Lewis, George K., Gallo, Robert C., DeVico, Anthony L., Fouts, Timothy R.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2016
Aiheet:
Vaccines
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4933776/
https://ncbi.nlm.nih.gov/pubmed/27193040
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00115-16
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia